|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||
|
||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sC0368F0A-59CA-11EF-AE4E-410A85CE164B&I=39IZM&T=&OP=Display&O=html&O1=15047444&O2=954927669269&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DEfficacy%2520and%2520safety%2520of%2520cetuximab%252Birinotecan%2520for%2520unresectable%2520advanced%2520or%2520recurrent%2520colorectal%2520cancer%26rft.au%3DAkatsuka%252C%2520Sotaro%26rft.au%3DArioka%252C%2520Hitoshi%26rft.au%3DNemoto%252C%2520Hiroshi%26rft.au%3DSoda%252C%2520Hitoshi%26rft.date%3D2013-05-01%26rft.externalDocID%3D23863582%26rft.genre%3Darticle%26rft.issn%3D0385-0684%26rft.issue%3D5%26rft.jtitle%3DGan%2520to%2520kagaku%2520ryoho%26rft.spage%3D605%26rft.volume%3D40%26rft_id%3Dinfo%253Apmid%252F23863582%26rft_id%3Dinfo%253Apmid%252F23863582%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-MESSAGE_NO_FULLTXT_LCL-getMessageNoFullTxt-object,2-COBIB_SI_LCL-getHolding-object,3-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,4-REFWORKS_EXPORT_TOOL-getReference-object,5-NCBI_PUBMED_FREE-getCitedRecord-object,6-GOOGLE_SCHOLAR_FREE-getWebSearch-object,7-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=0.884709&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15047444-sC0368F0A-59CA-11EF-AE4E-410A85CE164B" timestamp="2024-08-14T01:21:21Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954927669269</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>[Efficacy and safety of cetuximab+irinotecan for unresectable advanced or recurrent colorectal cancer].</jnl:atitle>
<jnl:jtitle>癌と化学療法</jnl:jtitle>
<jnl:date>2013-05-00</jnl:date>
<jnl:spage>605</jnl:spage>
<jnl:epage>608</jnl:epage>
<jnl:coden>GTKRDX</jnl:coden>
<jnl:issn>0385-0684</jnl:issn>
<jnl:volume>40</jnl:volume>
<jnl:issue>5</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2187-2449</jnl:eissn>
<jnl:language>jpn</jnl:language>
<jnl:coden>GTKRDX</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:c098e7e210c5f20fae1f6641451d3ea84591bc0b</ctx:identifier>
<ctx:identifier>urn:UUID:sC0368F0A-59CA-11EF-AE4E-410A85CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)